Browsing Tag
precision cardiology
2 posts
What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC
Could TN-401 reshape inherited heart disease treatment? Explore what Tenaya Therapeutics, Inc.’s RIDGE-1 data means for cardiac gene therapy.
Can RNA medicines really reach the heart? Atrium Therapeutics (Nasdaq: RNA) is putting $270m on the line
Atrium Therapeutics launches with $270 million to advance RNA medicines for rare genetic cardiomyopathies. Find out why investors are watching closely.